Can-Fite BioPharma Ltd. buy Lokrim
Start price
22.02.21
/
20%
€21.80
Target price
22.02.22
-
Performance (%)
-46.79%
End price
14.11.21
€11.60
Summary
This prediction ended on 14.11.21 with a price of €11.60. Massive losses of -46.79% were the result for the BUY prediction by Lokrim. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Can-Fite BioPharma Ltd. | - | - | - | - |
| iShares Core DAX® | -0.676% | 4.053% | 2.212% | 52.786% |
| iShares Nasdaq 100 | 0.993% | 10.872% | 38.041% | 94.873% |
| iShares Nikkei 225® | 3.279% | 13.468% | 59.003% | 70.295% |
| iShares S&P 500 | 0.621% | 6.195% | 26.154% | 68.910% |
According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Can-fite Biopharma Ltd. diskutieren
Buy Can-fite Biopharma Ltd.
In the thread Trading Can-fite Biopharma Ltd.
Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.
Start price
Target price
Perf. (%)
€11.60
14.11.21
14.11.21
-
14.11.22
14.11.22
-33.62%
15.11.22
15.11.22
Probably not worthwhile Investment
